CellSolutions, LLC.

CellSolutions, LLC. is a company focused on providing innovative solutions in the cytology sector, specializing in sample collection and preservation, as well as digital evaluation of cytological samples. Founded in 2007 and headquartered in Greensboro, US, CellSolutions, LLC. specializes in products for the cytology sector.

The company has raised USD 0. 45 mn in Seed funding, with its most recent deal occurring on June 4, 2018. The firm has completed a total of 2 deals. The CEO is Ernest Knesel, who leads the company in its strategic initiatives.

CellSolutions specializes in innovative products and services tailored for the cytology sector, focusing on sample collection, preservation, slide preparation, and digital evaluation of liquid-based cytology samples. Their core offerings include the BestCyte automated cytology screening system, which enables high-resolution, digital cellular image presentations for diagnostic reviews. This web-based software supports secure remote screening and diagnosis, primarily addressing the needs of laboratories handling cervical cytology. In addition, CellSolutions provides unique preservative solutions that maximize cell preservation and minimize unsatisfactory specimens, ensuring high-quality cell presentations for various cytology specimens.

Their products serve a diverse client base, including clinical laboratories and medical facilities across North America, Europe, and Asia, where they aim to enhance the efficiency and accuracy of diagnostic processes. CellSolutions generates revenue through direct sales of its advanced cytology products and services, including flagship offerings like the BestCyte system and its accompanying preservative solutions. The company engages with customers primarily through B2B transactions, partnering with clinical laboratories that require efficient and reliable cytology solutions. Revenue is structured around equipment sales, ongoing service agreements, and potentially subscription models for software updates and support.

Specific pricing structures for the products and services are tailored to the needs of their clients, reflecting the value of enhanced diagnostic capabilities and improved laboratory workflows. CellSolutions plans to utilize its most recent seed funding of USD 0. 45 mn, raised in June 2018, to support the development of new products aimed at expanding its market reach. The company is focusing on introducing new technologies that improve specimen adequacy and diagnostic accuracy.

Furthermore, CellSolutions intends to expand into new geographical regions, specifically targeting growth in Europe and Asia by the end of 2025.